MetLife Q2FY26 Results: Adjusted earnings rise 15% to $1.6 billion
- Adjusted earnings rose 15% YoY to $1.6 billion, with EPS up 20% to $2.43
- Group Benefits adjusted earnings surged 25% on favorable mortality trends
- New $3 billion share repurchase authorization announced alongside strong capital position
- International sales drove 7% overall growth, with Asia and LatAm leading
*this image is generated using AI for illustrative purposes only.
MetLife Inc reported adjusted earnings of $1.6 billion for the second quarter of fiscal year 2026, marking a 15% increase year over year. Adjusted earnings per share (EPS) grew 20% to $2.43, outpacing total earnings growth due to disciplined capital management and share repurchases.
The insurer’s performance was underpinned by broad-based growth across its business segments, with adjusted premiums, fees, and other revenues rising 5% excluding pension risk transfers. Sales increased 7%, led by strong momentum in international markets, particularly in Asia and Latin America.
Segment Performance Highlights
MetLife’s diversified portfolio contributed to balanced growth, with every business segment reporting higher adjusted earnings compared to the prior-year period. Group Benefits stood out with a 25% increase in adjusted earnings, driven by favorable life underwriting and a group life mortality ratio of 79%, significantly better than the annual target range of 83% to 88%.
| Segment | Adjusted Earnings | YoY Change | Key Driver |
|---|---|---|---|
| Group Benefits | $503 million | +25% | Favorable mortality |
| Asia | $420 million | +21% | Volume growth |
| RIS | $377 million | +2% | Interest margins |
| Latin America | $268 million | +15% | Record quarterly result |
| EMEA | $108 million | +8% | Sales momentum |
| MIM | $57 million | +6% | PineBridge integration |
Retirement and Income Solutions (RIS) generated $377 million in adjusted earnings, up 2%, as favorable recurring interest margins offset lower variable investment income. In Asia, adjusted earnings rose 21% on a reported basis, supported by equity market tailwinds in Korea and product innovation in Japan. Latin America delivered a quarterly record with $268 million in adjusted earnings, reflecting robust volume growth despite currency headwinds.
Capital Management and Shareholder Returns
The company announced a new $3 billion share repurchase authorization, signaling confidence in its capital generation capabilities. During the quarter, MetLife repurchased approximately $700 million of common shares, bringing year-to-date shareholder returns through buybacks and dividends to over $2.4 billion through July.
Holding company cash and liquid assets ended the quarter at $3.4 billion, remaining within the target buffer of $3 billion to $4 billion. The direct expense ratio was maintained at 12.1%, aligning with full-year targets, even after absorbing approximately 50 basis points of impact from the integration of PineBridge Investments.
What the Numbers Show
A divergence exists between net income and adjusted earnings, where net income totaled $705 million ($1.09 per share) compared to adjusted earnings of $1.6 billion. This gap is primarily attributed to mark-to-market accounting on derivatives and net investment losses, which are excluded from adjusted metrics. Furthermore, while total investment spread in RIS was 97 bps, below the guidance range of 100 to 120 bps due to weaker private equity returns, the core spread excluding variable investment income remained healthy at 100 bps, indicating stable underlying asset deployment.
How might the divergence between net income and adjusted earnings due to mark-to-market accounting influence investor sentiment in upcoming quarters?
Can MetLife sustain the 79% group life mortality ratio, or is a reversion toward the 83-88% target range expected as underwriting conditions normalize?
What specific regulatory or market challenges could impact the integration of PineBridge Investments given the noted 50 basis points expense drag?
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
